Market Commentary - Stock Alert
SBI, Infosys, Gland Pharma to be watched As on : 28-Jun-23  08:33

SBI: Executive Committee of the Central Board (ECCB) of the bank has accorded approval for acquiring the entire 20% stake held by SBI Capital Markets in SBI Pension Funds by SBI.

S&P Global Ratings has revised upward assessment of the stand-alone credit profiles (SACPs) of State Bank of India (SBI) by one notch to bbb from bbb-. The outlook on SBI remains stable.

Infosys: Infosys announced that it has signed a Memorandum of Understanding (MoU) with Skillsoft, a leading provider of transformative learning experiences, to revamp education and learning for students from class 6 to lifelong learners in India.

Gland Pharma: The United States Food and Drug Administration (US FDA) has conducted Pre-Approval Inspection (PAI) for Seven Products and Good Manufacturing Practice (GMP) Inspection at the Company's Pashamylaram Facility at Hyderabad between 15th June 2023 and 27th June 2023. The inspection was concluded with one 483 Observation.

Titagarh Rail Systems: The company has received Letter of Acceptance (LOA) from the Gujrat Metro Rail Corporation (GMRC) for Design , Manufacture, Supply, Testing, Commissioning and Training of 72 nos. of Standard Gauge Cars for Surat Metro Rail Phase-I Project I. The order value is about Rs 857 crore.

The Ramco Cements: The company has commissioned Line III at Ramamasamy Raja Nagar of 3,000 TPD capacity of clinkerisation. With the commissioning of Line III clinker manufacturing facility, the requirement of limestone has gone up.

Shalby: The company has signed an agreement with Divine Super Specialty Hospital Pvt. Ltd., a hospital in Ranchi having capacity of 60 beds, to establish a Franchise‐Owned Shalby‐Managed (FOSM) hospital in the region.

Powered by Capital Market - Live News